启明创投胡旭波：人工智能公司有泡沫，但行业没有泡沫

Core Viewpoint - The discussion at the 25th China Private Equity Annual Conference highlighted the ongoing debate about the artificial intelligence bubble, with a focus on investment opportunities in technology and medical innovation sectors [2][4]. Group 1: Investment Focus - Qiming Venture Partners primarily invests in technology and medical innovation industries, with a significant emphasis on the application layer of artificial intelligence as a key investment direction for the year [2][4]. - In the medical innovation sector, the main theme of investment is the globalization of China's pharmaceutical innovation capabilities, including innovative drugs and medical devices [2][4]. Group 2: Industry Perspective - The firm supports investments that integrate companies into the global medical industry chain, encompassing research and development innovation and the establishment of a comprehensive commercialization system [2][4]. - Despite the presence of bubbles in many companies within the artificial intelligence and medical innovation fields, the firm does not believe that the overall industry is experiencing a bubble [2][4].